Malene Jensen has been appointed head of clinical development at Medivir AB to lead development of the Swedish company’s drug portfolio. She will take up her new role in the autumn having previously served as director of global clinical development at Sedana Medical AB, a medical technology company. Dr Jensen has also held leadership positions at AstraZeneca Plc and Affibody AB of Sweden. She holds a PhD in clinical neuroscience from the Karolinska Institutet in Stockholm.
Medivir announced the appointment on 1 July 2021
Copyright 2021 Evernow Publishing Ltd